| Symbol | TXMD |
|---|---|
| Name | THERAPEUTICSMD, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 951 YAMATO ROAD,SUITE 220, BOCA RATON, Florida, 33431, United States |
| Telephone | +1 561 - 961-1900 |
| Fax | — |
| — | |
| Website | https://www.therapeuticsmd.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000025743 |
| Description | TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMDs drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates. Additional info from NASDAQ: |
New Form SCHEDULE 13G - TherapeuticsMD, Inc. <b>Filed:</b> 2026-04-06 <b>AccNo:</b> 0001493152-26-015371 <b>Size:</b> 25 KB
Read moreNew Form 10-K - TherapeuticsMD, Inc. <b>Filed:</b> 2026-03-30 <b>AccNo:</b> 0001213900-26-036515 <b>Size:</b> 8 MB
Read moreThompson Tommy G 🟢 acquired 8.4K shares of TherapeuticsMD, Inc. (TXMD) at $1.67 Transaction Date: Dec 23, 2025 | Filing ID: 004488
Read moreThompson Tommy G 🟢 acquired 8.5K shares (1 derivative) of TherapeuticsMD, Inc. (TXMD) Transaction Date: Nov 03, 2025 | Filing ID: 003785
Read moreNaughton Gail K 🟢 acquired 8.5K shares (1 derivative) of TherapeuticsMD, Inc. (TXMD) Transaction Date: Nov 03, 2025 | Filing ID: 003784
Read more